In plain English
Outlook Therapeutics Inc. develops biologic medicines and related therapies, focusing on eye disease treatments. The company recently…
Company stock · NASDAQ NMS - GLOBAL MARKET · USD
Outlook Therapeutics Inc
$0.52
Today
−$0.04-7.84%
vs yesterday’s close
Live price
Price chart Pro
Company briefing
Plain English context — why the name shows up in the news, and what to watch next.
Outlook Therapeutics Inc. develops biologic medicines and related therapies, focusing on eye disease treatments. The company recently…
Latest on this name
1 recent card — open any for the full deeper dive.
The S&P 500 hit a new record high after PPI data showed mixed economic signals, with the Fear & Greed Index improving but remaining in the 'Greed' zone.
Company reports
No filings here yet
Official report cards for OTLK will show up here when available.
Broad market indexes (like the S&P 500, a basket of 500 large US companies) are shown through popular funds that track them (for example SPY). Company profile and prices use live market data when available.